甘肃普安制药

Gansu Puan Pharmaceutical is a specialized pharmaceutical company based in China, primarily focused on the development and production of Traditional Chinese Medicine (TCM). A subsidiary of the state-owned Gansu Nongken Group, the company is best known for its flagship product, Xuanfei Zhike Particles, which is widely used for treating respiratory conditions such as cough and bronchitis. This product gained significant national prominence after being included in official Chinese government treatment protocols for COVID-19 symptoms. Operating out of Wuwei, Gansu, the company utilizes local botanical resources to manufacture GMP-certified herbal treatments. Puan Pharmaceutical is listed on the National Equities Exchange and Quotations (NEEQ) and maintains a strong presence in the domestic respiratory medicine market.